Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2025-12-26 @ 12:30 AM
Study NCT ID:
NCT01392560
Status:
COMPLETED
Last Update Posted:
2014-06-17
First Post:
2011-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-11
First Submit QC Date:
None
Study First Post Date:
2011-07-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-16
Results First Submit QC Date:
None
Results First Post Date:
2014-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-16
Last Update Post Date:
2014-06-17
Last Update Post Date Type:
ESTIMATED